West Pharmaceutical Services UK
WST NYSE
SEC CIK 105770
Follow West Pharmaceutical Services UK
Weekly email: filings, results, news
Revenue, last quarter
$872.3M
+13.8% vs same quarter last year
Net income
$154M
+16.8% vs same quarter last year
EPS, diluted
$2.15
+18.1% vs same quarter last year
Operating cash flow
$124M
−30% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $3.1B | $493.7M |
| FY24 | $2.9B | $492.7M |
| FY23 | $2.9B | $593.4M |
| FY22 | $2.9B | $585.9M |
| FY21 | $2.8B | $661.8M |
| FY20 | $2.1B | $346.2M |
| FY19 | $1.8B | $241.7M |
| FY18 | $1.7B | $206.9M |
| FY17 | $1.6B | $150.7M |
| FY16 | $1.5B | $143.6M |
| FY15 | $1.4B | $95.6M |
| FY14 | $1.4B | $127.1M |
| FY13 | $1.4B | $112.3M |
| FY12 | $1.3B | $80.7M |
| FY11 | $1.2B | $75.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 35.9% | 19% | 16.1% |
| FY24 | 34.5% | 19.7% | 17% |
| FY23 | 38.3% | 22.9% | 20.1% |
| FY22 | 39.4% | 25.4% | 20.3% |
| FY21 | 41.5% | 26.6% | 23.4% |
| FY20 | 35.8% | 19% | 16.1% |
| FY19 | 32.9% | 16.1% | 13.1% |
| FY18 | 31.8% | 14% | 12% |
| FY17 | 32.1% | 14.1% | 9.4% |
| FY16 | 33.2% | 12.9% | 9.5% |
| FY15 | 32.6% | 9.2% | 6.8% |
| FY14 | 31.5% | 12.8% | 8.9% |
| FY13 | 31.8% | 11.9% | 8.2% |
| FY12 | 30.6% | 10.7% | 6.4% |
| FY11 | 28.5% | 9.2% | 6.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $468.9M |
| FY24 | $276.4M |
| FY23 | $414.5M |
| FY22 | $439.4M |
| FY21 | $330.6M |
| FY20 | $298.1M |
| FY19 | $240.8M |
| FY18 | $183.9M |
| FY17 | $132.5M |
| FY16 | $49.2M |
| FY15 | $80.8M |
| FY14 | $71M |
| FY13 | $68.6M |
| FY12 | $56.1M |
| FY11 | $35.3M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $61.2M | $134M |
| FY24 | $59.1M | $560.9M |
| FY23 | $57M | $438.3M |
| FY22 | $54.1M | $202.8M |
| FY21 | $51.1M | $137.1M |
| FY20 | $48.1M | $115.5M |
| FY19 | $45.1M | $83.1M |
| FY18 | $42.1M | $70.8M |
| FY17 | $39.1M | $74.4M |
| FY16 | $35.8M | $52.2M |
| FY15 | $32.4M | $0 |
| FY14 | $29.1M | $0 |
| FY13 | $26.7M | - |
| FY12 | $24.9M | $4.7M |
| FY11 | $23.2M | $3.5M |
- West Pharmaceutical Services UK
- Healthcare median
Show the numbers
| Year | West Pharmaceutical Services UK | Healthcare median |
|---|---|---|
| FY25 | 16.1% | −63.2% |
| FY24 | 17% | −86.4% |
| FY23 | 20.1% | −123.6% |
| FY22 | 20.3% | −138.2% |
| FY21 | 23.4% | −139.8% |
| FY20 | 16.1% | −143.7% |
| FY19 | 13.1% | −143.3% |
| FY18 | 12% | −173.4% |
| FY17 | 9.4% | −166.7% |
| FY16 | 9.5% | −173.8% |
| FY15 | 6.8% | −183.4% |
| FY14 | 8.9% | −133.4% |
| FY13 | 8.2% | −88.5% |
| FY12 | 6.4% | −87.4% |
| FY11 | 6.3% | −76.3% |